My NCBISign In

Display Settings:

Format

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

AIDS Res Ther. 2010 Jul 21;7:24.

Co-receptor tropism prediction among 1045 Indian HIV-1 subtype C sequences: Therapeutic implications for India.

Neogi U, Prarthana SB, D'Souza G, Decosta A, Kuttiatt VS, Ranga U, Shet A.

Department of Pediatrics, St, John's Medical College and Hospital, St, John's National Academy of Health Sciences, Sarjapur Road, Bangalore-560034, India. anitashet@gmail.com.

Abstract

ABSTRACT:

BACKGROUND: Understanding co-receptor tropism of HIV-1 strains circulating in India will provide key analytical leverage for assessing the potential usefulness of newer antiretroviral drugs such as chemokine co-receptor antagonists among Indian HIV-infected populations. The objective of this study was to determine using in silico methods, HIV-1 tropism among a large number of Indian isolates both from primary clinical isolates as well as from database-derived sequences.

RESULTS: R5-tropism was seen in 96.8% of a total of 1045 HIV-1 subtype C Indian sequences. Co-receptor prediction of 15 primary clinical isolates detected two X4-tropic strains using the C-PSSM matrix. R5-tropic HIV-1 subtype C V3 sequences were conserved to a greater extent than X4-tropic strains. X4-tropic strains were obtained from subjects who had a significantly longer time since HIV diagnosis (96.5 months) compared to R5-tropic strains (20.5 months).

CONCLUSIONS: High prevalence of R5 tropism and greater homogeneity of the V3 sequence among HIV-1 subtype C strains in India suggests the potential benefit of CCR5 antagonists as a therapeutic option in India.

PMID: 20646329 [PubMed - in process]PMCID: PMC2918521Free PMC Article

Supplemental Content

Click here to read Click here to read

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk